Down-regulation of osteopontin attenuates breast tumour progression in vivo
Development of breast tumour malignancies results in enhanced expression of various oncogenic molecules. Elevated expression of osteopontin (OPN) in higher grades of breast carcinoma correlates with enhanced expressions of several oncogenic molecules (urokinase-type plasminogen activator [uPA], matr...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
John Wiley & Sons, Ltd
2008
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514110/ |